Allogeneic adipose-derived stem cells suppress Th17 lymphocytes in patients with active lupus in vitro

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 10, 2011, Pages 805-812

  Lai, Kuan ^a   Zeng, Kang ^a   Zeng, Fanqin ^b   Wei, Jing ^b   Tan, Guozhen ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

adipose derived stem cells; cell therapy; IL 23; systemic lupus erythematosus; Th17

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; BIOLOGICAL THERAPY; CELL CULTURE; CYTOLOGY; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; STEM CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL;

ADIPOSE TISSUE; ADOLESCENT; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; STEM CELLS; TH17 CELLS; TISSUE THERAPY; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 80053531758     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr077     Document Type: Article

References (26)

1. Fang B, Song YP, Liao LM, Han Q and Zhao RC. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissuederived mesenchymal stem cells. Bone Marrow Transplant 2006, 38: 389-390.
2. Le BK, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M and Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363: 1439-1441. (Pubitemid 38586721)
3. Ryan JM, Barry FP, Murphy JM and Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2005, 2: 8.
4. Cui L, Yin S, Liu W, Li N, Zhang W and Cao Y. Expanded adiposederived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007, 13: 1185-1195. (Pubitemid 46986719)
5. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C and Taureau C, et al. Immunomodulatory effect of human adipose tissuederived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005, 129: 118-129. (Pubitemid 40524060)
6. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R and Bouloumie A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004, 110: 349-355. (Pubitemid 38955505)
7. Kim WS, Park BS and Sung JH. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther 2009, 9: 879-887.
8. Shen H, Goodall JC and Hill GJ. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009, 60: 1647-1656.
9. Lubberts E. IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis? Cytokine 2008, 41: 84-91.
10. Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang X and Wan L, et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009, 60: 1472-1483.
11. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ and Benhaim P, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001, 7: 211-228. (Pubitemid 32295155)
12. Liu H and Rohowsky-Kochan C. Regulation of IL-17 in human CCR6+ effector memory T cells. J Immunol 2008, 180: 7948-7957.
13. Koga C, Kabashima K, Shiraishi N, Kobayashi M and Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008, 128: 2625-2630.
14. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M and Dragoo JL, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 174: 101-109. (Pubitemid 36819010)
15. Fang B, Song Y, Zhao RC, Han Q and Lin Q. Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis. Transplant Proc 2007, 39: 1710-1713. (Pubitemid 46907940)
16. Zuk PA, Zhu M, Ashjian P, De UD, Huang JI, Mizuno H and Alfonso ZC, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13: 4279-4295. (Pubitemid 35471185)
17. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM and Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6: 1123-1132. (Pubitemid 41541790)
18. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK and Armitage RJ. Human IL-17: A novel cytokine derived from T cells. J Immunol 1995, 155: 5483-5486.
19. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS and Bowman EP, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008, 128: 1207-1211. (Pubitemid 351543220)
20. Lu TT, Zhu P, Li XY and Fan CM. Functional status of T helper cells in rheumatoid arthritis and effect of etanercept. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2008, 24: 495-497.
21. Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y and Takabayashi K, et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 2000, 43: 2455-2463.
22. Wong CK, Lit LC, Tam LS, Li EK, Wong PT and Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in autoimmunity. Clin Immunol 2008, 127: 385-393.
23. Ko E, Cho KA, Ju SY and Woo SY. Mesenchymal stem cells inhibit the differentiation of CD4+ T cells into interleukin-17-secreting T cells. Acta Haematol 2008, 120: 165-167.
24. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD and Basham B, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8: 950-957. (Pubitemid 47300009)
25. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, Watanabe K and Ito K, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008, 127: 78-88.
26. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B and Lucian L, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421: 744-748. (Pubitemid 36227625)